DIVISLAB.NS

Divi's Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$6,743.00

-0.69%Jun 19, 2026

AI Brief

Market cap

$1.79T

52w range

—

P / E

—

EPS · FY 2026

$96.75

Volume

—

Revenue · FY 2026

$105.6B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Divi's Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$6743.00

Change

+1.61%

Period high

$6983.50

Period low

$5689.50

Period start

$6636.002025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$2,112.87

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

DIVISLAB.NS

6,743+1.61%

H 7,072L 5,637MA50 6,568MA200 6,346Avg vol 368K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Technology
+2.51%
Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Industrials
+0.22%
Consumer Defensive
-0.30%
Real Estate
-0.34%
Energy
-0.45%
Basic Materials
-0.66%
Financial Services
-0.67%
Healthcare
-1.51%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-0.91%
Electronic Gaming & Multimedia
+7.50%
Business Equipment & Supplies
+5.82%
Semiconductors
+5.24%
Advertising Agencies
-5.20%
Medical - Equipment & Services
+5.08%
Oil & Gas Energy
-4.86%
Consulting Services
-4.82%
Grocery Stores
-4.35%
Computer Hardware
-3.67%
Coal
-3.56%
Other Precious Metals
-3.55%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for DIVISLAB.NS.

Peers

No peer list available for DIVISLAB.NS.

Total assets

$200.33B

Total debt

$70M

Cash & equiv

$34.14B

Operating CF

$30.17B

Free cash flow

$4.97B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$105.6B	$29.78B	$25.68B	$96.75	+24.32%